Most Popular Angioplasty Web Site
Dr. Gary Roubin Named Director of Cardiovascular Services at Continuum Health Partners in New York
Share This Story:
Bookmark and Share

external sites:
Continuum Health Partners

Gary S. Roubin, MD,
Gary S. Roubin, MD, PhD, FSCAI
July 24, 2012 -- New York -- World-renowned interventional cardiologist and stent pioneer Gary Roubin, MD, PhD, FSCAI will be joining Continuum Health Partners in New York City as of August 1 in a newly created role: Director of the Cardiovascular Service Line. Continuum Health Partners currently includes Beth Israel Medical Center, St. Luke's Hospital, Roosevelt Hospital and The New York Eye & Ear Infirmary. In his new position, Dr. Roubin will lead all components of the Continuum hospitals' cardiac service divisions.

Last January, Angioplasty.Org reported that Roubin was stepping down as Chair of Interventional Cardiac & Vascular Services at Lenox Hill Heart and Vascular Institute after almost a decade in that position. Dr. Roubin has been involved with interventional cardiology since he worked with Dr. Andreas Gruentzig, the inventor of coronary angioplasty. Dr. Roubin is credited with designing the first FDA-approved coronary stent, while at Emory Hospital: the Gianturco-Roubin Flex Stent™. He was also a driving force in the CREST trial which validated the use of carotid stents.

Gary Roubin has also persevered in keeping alive Gruentzig's original vision of angioplasty and its application to the care of patients. As President of the International Andreas Gruentzig Society, he, along with Dr. Bernhard Meier of Switzerland, organized the 30th Anniversary of Angioplasty in 2007, bringing together the pioneers of this field of medicine in an emotional reunion in the Zurich hospital auditorium where it all began.

More about Dr. Roubin and his new position can be read in this information release from Continuum:

"While serving as Chairman of the Department of Cardiovascular Medicine at Lenox Hill Hospital for the past eight years, he was instrumental in building one of New York City's most successful interventional cardiology programs and in developing and directing a flourishing multidisciplinary cardiovascular service program with an unwavering commitment to excellent medical outcomes. In his prior six years as Chief of Endovascular Services at Lenox Hill Heart and Vascular Institute, he successfully coordinated the largest multidisciplinary service of cardiologists, vascular surgeons and radiologists in the region.

"Dr. Roubin's vast experience and immeasurable professional and clinical triumphs will serve our patients and hospitals well. Working collaboratively with his colleagues in the Departments of Medicine and Surgery, Dr. Roubin will develop the plan for increased coordination of medical and surgical cardiac services across our campuses. Building on the existing talent of the system's cardiologists and cardiac surgeons, he will employ his extensive expertise to elevate our cardiovascular services to the highest possible standards of excellence in patient care and outcomes. He also will focus on the recruitment of additional experts to both complement and expand our services. Reflecting the integrative role that cardiovascular services play in our hospitals, Dr. Roubin will be active at all our sites.

"Prior to coming to New York City, Dr. Roubin held Chairs in Cardiovascular Medicine and Radiology at the University of Alabama at Birmingham. A native of Australia, Dr. Roubin earned his medical degree at the University of Queensland in 1975. He performed his residency at the Royal Prince Alfred Hospital and his fellowship at the Hallstrom Institute of Cardiology in Sydney. In 1983, he received his doctoral degree in cardiovascular physiology at Sydney University. Dr. Roubin is widely published in international peer review journals and a member of many professional societies. He has played a pivotal role in many notable NHLBI studies on coronary and carotid disease."

Reported by Burt Cohen, July 24, 2012